Full text is available at the source.
mRNA vaccination may overcome malaria vaccine problems caused by parasite pigment in mice
Updated
Abstract
Essence
An mRNA malaria vaccine strategy overcame haemozoin-linked weakening of whole-parasite vaccine protection in malaria-exposed mice.
Evidence
This preclinical mouse study showed prior blood-stage Plasmodium yoelii exposure impaired Plasmodium berghei RAS-induced CD8 T cell responses, while a lipid nanoparticle mRNA vaccine encoding Plasmodium CD8 T cell epitopes restored protection.
Caveat
The findings are from murine malaria-experience models, so they do not establish vaccine efficacy in people living in malaria-endemic regions.
Simplified
mRNA Technology